Neutralising antibody molecules having specificity for human IL-17
US8231875B2 · kind B2 · utility
13Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2005 |
| Grant date | Jul 31, 2012 |
| Priority date | — |
| Expiry date | Jan 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.